search icon

      Market Snapshot

      blog search icon

      HBIO Stock Price History and Quote Analysis: Insights for Investors

      Harvard Bioscience, Inc.

      (NASDAQ:HBIO)

      $4.11

      0.02 (0.49%)

      At Close: 4:00 PM

      $4.10

      0.00 (0.00%)

      Pre Market: 4:32 AM

      HBIO Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      HBIO Stock Price Today

      Harvard Bioscience, Inc. (HBIO) stock rallied over 0.49% intraday to trade at $4.11 a share on NASDAQ. The stock opened with a loss of -0.24% at $4.08 and touched an intraday high of $4.14, rising 0.49% against the last close of $4.09. The Harvard Bioscience, Inc. in stock market went to a low of $4.03 during the session.

      HBIO Stock Snapshot

      $4.09

      Prev. Close

      175.46 Million

      Market Cap

      $4.03

      Day Low

      $4.08

      Open

      N/A

      Number of Shares

      $4.14

      Day High

      N/A

      P/E ratio

      -0.13

      EPS (TTM)

      0.10

      Cash Flow per Share

      N/A

      Free Float in %

      1.77

      Book Value

      101238.00

      Volume

      HBIO Stock Price History Chart

      DateOpenHighLowCloseVolume

      Contact Details

      84 October Hill Road
      Holliston, MA 01746
      US

      Website:https://www.harvardbioscience.com

      Contact #:508 893 8999

      Company Information

      EmployeesN/A

      BetaN/A

      Sales or Revenue$114.08 Million

      5Y Sales Change10.38%

      Fiscal Year EndsDec. 2022

      SectorHealthcare

      IndustryMedical Instruments & Supplies

      About Company

      Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.

      Peers

      Frequently Asked Questions

      icon

      What is the current Harvard Bioscience, Inc. (HBIO) stock price?

      Harvard Bioscience, Inc. (NASDAQ: HBIO) stock price is $4.11 in the last trading session. During the trading session, HBIO stock reached the peak price of $4.14 while $4.03 was the lowest point it dropped to. The percentage change in HBIO stock occurred in the recent session was 0.49% while the dollar amount for the price change in HBIO stock was $0.02.

      icon

      HBIO's industry and sector of operation?

      The NASDAQ listed HBIO is part of Medical Instruments & Supplies industry that operates in the broader Healthcare sector. Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally.

      icon

      Who are the executives of HBIO?

      Mr. James W. Green
      Pres, Chief Executive Officer & Chairman
      Mr. Kenneth Fletcher Olson
      Executive Officer
      Mr. Michael A. Rossi
      Chief Financial Officer
      David Sirois
      Director of Corporation Accounting & SEC Reporting

      icon

      How HBIO did perform over past 52-week?

      HBIO's closing price is 2.10% higher than its 52-week low of $1.98 where as its distance from 52-week high of $6.29 is -0.02%.

      icon

      How many employees does HBIO have?

      Number of HBIO employees currently stands at N/A. HBIO operates from 84 October Hill Road, Holliston, MA 01746, US.

      icon

      Link for HBIO official website?

      Official Website of HBIO is: https://www.harvardbioscience.com

      icon

      How do I contact HBIO?

      HBIO could be contacted at phone #508 893 8999 and can also be accessed through its website. HBIO operates from 84 October Hill Road, Holliston, MA 01746, US.

      icon

      How many shares of HBIO are traded daily?

      HBIO stock volume for the day was 101238.00 shares. The average number of HBIO shares traded daily for last 3 months was 161.57 Thousands.

      icon

      What is the market cap of HBIO currently?

      The market value of HBIO currently stands at $175.46 Million with its latest stock price at $4.11 and N/A of its shares outstanding.